Loading clinical trials...
Loading clinical trials...
A Randomized, 4-Sequence, Double-Blind Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude
Conditions
Interventions
Aminophylline 400 mg
Ambrisentan 5 mg
+1 more
Locations
2
United States
Duke Center for Hyperbaric Medicine
Durham, North Carolina, United States
Duke Clinical Research Unit (DCRU)
Durham, North Carolina, United States
Start Date
September 1, 2013
Primary Completion Date
September 1, 2014
Completion Date
December 1, 2014
Last Updated
November 13, 2015
Lead Sponsor
Robert J Noveck, M.D.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions